Lung Cancer
Avida (Trastuzumab Rezetecan) – NSCLC | HongKong DengYue Medicine
Airuikai (Glecirasib Citrate) – NSCLC | HongKong DengYue Medicine
Aoyixin (Limertinib) – NSCLC | HongKong DengYue Medicine
Hycamtin (Topotecan Hydrochloride) – Malignancies | HongKong DengYue Medicine
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
YERVOY (Ipilimumab) – Advanced Malignancies | HongKong DengYue Medicine
Rybrevant (Amivantamab) – NSCLC | HongKong DengYue Medicine
ORPATHYS (Savolitinib Tablets) – NSCLC | HongKong DengYue Medicine
Ttarisso (Osimertinib) – NSCLC | HongKong DengYue Medicine
Rozlytrek (Entrectinib) – NSCLC | HongKong DengYue Medicine
Tarceva (Erlotinib) – NSCLC & Pancreatic Cancer | HongKong DengYue Medicine
Daboshu (Sintilimab Injection) – Lung Cancer | HongKong DengYue Medicine
Tuoyi (Toripalimab) – Nasopharyngeal Carcinoma | HongKong DengYue Medicine
Tafinlar (Dabrafenib Mesylate) – Melanoma & Lung Cancer | DengYue Medicine
Firmonertinib Mesilate Tablets – NSCLC | HongKong DengYue Medicine
Zegfrovy (Sunvozertinib) | NSCLC | HongKong DengYue Med
